Half of U.S. Doctors Receive Payments From Industry
And, market share for brand-name drugs down at hospitals with sales restrictions
April 2017 Briefing – Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for April 2017. This roundup includes the latest...
Meeting Organizers Overlooking Qualified Female Scientists
Active generation of lists of potential speakers, assessment of qualifications can address bias
Single-Payer Health System Bill Moves Forward in California
Not yet clear where money for the single-payer system would come from
MTX + Adalimumab Beneficial in JIA-Associated Uveitis
In children with active juvenile idiopathic arthritis, the combination controls eye inflammation
Risk Factors in Six Areas Tied to Physician Burnout
Tool gauging burnout focuses on workload, control, rewards, community, fairness, values
Undiagnosed Macular Degeneration Appears Common
Nearly one-fourth of eyes deemed normal in primary care eye exam found to have AMD
Three Anti-VEGF Treatments Effective for Diabetic Retinopathy
Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab
Post-Op hsTnT Linked to 30-Day Mortality After Noncardiac Sx
Increased risk of 30-day mortality for absolute high-sensitivity troponin T change of 5ng/L or higher
Gene Therapy Strategy Feasible for Retinitis Pigmentosa
Reprogramming rod to cone-like photoreceptors by inactivation of Nrl or Nr2e3 restores visual function
